Depressive Disorders and Cardiovascular Medicine Lawson Wulsin, MD Copyright © 2011. World Psychiatric Association.

Slides:



Advertisements
Similar presentations
Peripheral Arterial Disease Mehul Bhatt, MD Interventional Cardiology / Vascular Medicine Athens Heart Center.
Advertisements

Chronic Kidney Disease and Heart Disease: Understanding the Link Contributed by Elaine M. Koontz, RD, LD/N Review Date 8/13 R-0629 Provided Courtesy of.
Pablo M. Bedano M.D. Community Regional Cancer Care.
ESAs and Outcomes in CKD Patients Philip Lui PharmD The 13th Annual Contemporary Therapeutic Issues in Cardiovascular Disease May 8, 2010.
Clinical Trial Results. org Tilman B. Drüeke, M.D.; Francesco Locatelli, M.D.; Naomi Clyne, M.D.; Kai-Uwe Eckardt, M.D.; Iain C. Macdougall, M.D.; Dimitrios.
PAD A Call to Action. PAD: A Call to Action - What is peripheral arterial disease (PAD)? and why is it so dangerous? - Diagnosing PAD in the primary care.
Journal Reading Myocardial infarction in young people Cardiol J 2009; 16, 4: 307–311 Cardiol J 2008; 15: 21–25 Presented by R 王郁菁 at ER conference.
Monica Colvin-Adams, MD Assistant Professor of Medicine Advanced Heart Failure and Transplantation University of Minnesota Compassionate Allowances Outreach.
Research with clinical populations: Cardiac rehabilitation Shawn N Fraser University of Alberta.
CVD statistics Cardiovascular disease (CVD) is the leading cause of death in the U.S. CVD is the number one killer in the U.S. More that 2,500 Americans.
Management of Hypertension according to JNC 7 BY SANDAR KYI, MD.
Only You Can Prevent CVD Matthew Johnson, MD. What can we do to prevent CVD?
Ischemic heart disease
VBWG IDEAL: The Incremental Decrease in End Points Through Aggressive Lipid Lowering Study.
Orlando, Florida – October 7, 2011 Cardiac Rehab: Improving Outcomes One Step at a Time Martha Gulati MD, MS, FACC, FAHA Associate Professor of Medicine.
1 Dr. Zahoor Ali Shaikh. 2 CORONARY ARTERY DISEASE (CAD)  CAD is most common form of heart disease and causes premature death.  In UK, 1 in 3 men and.
Cardiac Arrhythmias in Coronary Heart Disease SIGN 94.
20 Cardiovascular Disease and Physical Activity chapter.
December Cardiac Rehabilitation Are you or someone you know missing the benefits of Cardiac Rehabilitation?
SIGN CHD In Scotland in the year ending 31 March 2006 over 10,300 patients died from CHD and 5,800 from cerebrovascular disease, with.
Depression as a Risk Factor for Ischemic Heart Disease Homayoun Amini M.D. Department of Psychiatry Roozbeh Hospital TUMS.
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial ALLHAT study overview Double-blind, randomized trial to determine whether.
Clinical implications. Burden of coronary disease 56 millions deaths worldwide in millions deaths worldwide in % due to CV disease (~ 16.
© Continuing Medical Implementation ® …...bridging the care gap Cardiovascular Aging.
Cardiovascular Disease in Women Module V: Prognosis and Treatment Outcomes.
Copyright © 2015 McGraw-Hill Education. All rights reserved. No reproduction or distribution without the prior written consent of McGraw-Hill Education.
HCS Objective To determine if measurement of postprandial TG level improves risk prediction of CV events over traditional risk markers in stable patients.
Effects of Depression on Risks and Prognosis of CV Disease Chad D. Foster.
Cardiovascular Disease CVD *Number one killer of adults *1 in 4 people living In the us is ill with some form of this.
Incremental Decrease in Clinical Endpoints Through Aggressive Lipid Lowering (IDEAL) Trial IDEAL Trial Presented at The American Heart Association Scientific.
Plasminogen-Activating Inhibitor-1 (PAI-1) High PAI-1 associated with: Obesity (especially visceral), possible fatty liver. 2,3,4 Inflammation and oxidative.
Minority Health Task Force Think Globally, Act Locally: How to Make a Difference in Your Neighborhood’s Health NAACP Health Workshop Saturday, October.
Cardiovascular Disorders
Hypertension Family Medicine Specialist CME October 15-17, 2012 Pakse.
Community Outreach to Reduce Disparities in Cardiovascular & Diabetes Morbidity & Mortality in the South Bronx Michael Alderman, MD Michelle Johnson, MD,
A-1 Introduction Pravastatin-Aspirin 7asdf Fred T. Fiedorek, M.D. Vice President, Clinical Design & Evaluation, Metabolics Pharmaceutical Research Institute.
ALLHAT 6/5/ CARDIOVASCULAR DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED BY BASELINE GLOMERULAR FILTRATION RATE (3 GROUPS by GFR)
 Heart disease remains the leading cause of morbidity and mortality in industrialized nations.  40% of all deaths in the U.S.A (nearly twice the number.
Coronary Heart Disease (CHD) László Tornóci Inst. Pathophysiology Semmelweis University.
Heart Failure Heart failure (HF) is a common clinical syndrome. Heart failure (HF) is a complex clinical syndrome that can result from any structural or.
Cardiovascular diseases Dr Hazem Al-Ahmad B.D.S, MSc(Lon), F.D.S.R.C.S (Eng)
6/5/ CARDIOVASCULAR DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED BY BASELINE GLOMERULAR FILTRATION RATE (4 GROUPS by GFR) ALLHAT.
Cardiovascular Disease Prevention Know, Understand, and Act University of Ottawa Heart Institute Division of Prevention & Rehabilitation.
Don’t Worry I am Ok! Goal of project GOAL OF PROJECT  TO AWARE ABOUT HEART DISEASES.  TO UNDERSTAND CAUSES OF HEART DISEASES.  TO AWARE PREVENTIVE.
Depression and cardiovascular disease an epidemiological perspective Nicole Vogelzangs Psychiatry / EMGO institute, VU University Medical Center.
Cardiovascular Disease Lesson 14.2 Page 414 in the book “Disease of the Heart and Blood Vessels”
The Impact of Clinical Depression On Chronic Medical Conditions Stephen W. Robinson, MD Assistant Professor Clerkship Director and Inpatient Director Department.
Date of download: 7/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Scope of Coronary Heart Disease in Patients With.
Management of Hypertension according to JNC 7
Transitions in Care-Heart Failure
Preventing Cardiovascular Disease
The Anglo Scandinavian Cardiac Outcomes Trial
Heart Rate, Life Expectancy and the Cardiovascular System: Therapeutic Considerations Cardiology 2015;132: DOI: / Fig. 1. Semilogarithmic.
PS Sever, PM Rothwell, SC Howard, JE Dobson, B Dahlöf,
Single Stage CABG and Peripheral Arterial Bypass for Combined Coronary and Peripheral Arterial Disease Divya Arora, Ashok Chahal and Shamsher Singh Lohchab.
First time a CETP inhibitor shows reduction of serious CV events
Prevention Cardiovascular disease
Fort Hays State University, Department of Nursing
Cardiovascular Disease
Effects of poor lifestyle choices on the cardiovascular system
Insights from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)
Exercise-Based Cardiac Rehabilitation and Improvements in Cardiorespiratory Fitness: Implications Regarding Patient Benefit  Barry A. Franklin, PhD  Mayo.
Smoking and cardiovascular outcomes in dialysis patients: The United States Renal Data System Wave 2 Study1,2  Robert N. Foley, Charles A. Herzog, Allan.
The Vascular Study Group of New England Cardiac Risk Index (VSG-CRI) predicts cardiac complications more accurately than the Revised Cardiac Risk Index.
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
Cause of death Treatment-arm events, % (n=45 054)
Association between the choice of anesthesia and in-hospital outcomes after carotid artery stenting  Hanaa Dakour-Aridi, MD, Muhammad Rizwan, MD, Besma.
PowerPoint 16:9 Screen Ratio Template *
Cardiovascular Epidemiology and Epidemiological Modelling
Presentation transcript:

Depressive Disorders and Cardiovascular Medicine Lawson Wulsin, MD Copyright © World Psychiatric Association

Introduction Major depression occurs 15-30% of ACS pts Depression triples post MI risk for death by 6 mos Screening for depression is not yet standard practice in most heart centers Depression reduces adherence to chronic regimens Depression reduces attendance at cardiac rehab Rudisch 2003; Glassman 1998; DiMatteo 2000; Copyright © World Psychiatric Association2

Depression as Risk for CV Morbidity and Mortality Depression independently raises the risk for the development of CHD (Coronary heart disease, impaired perfusion of the cardiac muscle because of narrowing of the coronary arteries or spasm of the coronary arteries leading to ischemia) In CHD pts, depression doubles the risk for CVD (Cardiovascular disease, any disease of the cardiovascular system, including hypertension, coronary heart disease, congestive heart failure, rheumatic heart disease, peripheral vascular disease, and stroke. CVD events and all-cause mortality Dose-response relationship between severity of depression and severity of CHD Linking mechanisms: –Smoking –Poor adherence –Platelet activation –Autonomic imbalance –Chronic low-grade inflammation 3Copyright © World Psychiatric Association

CVD as Risk for Depressive Disorders Vascular depression hypothesis –Decreased perfusion of limbic system contributes to late-onset depression risk High rates of “silent strokes” in depressed elderly 4Copyright © World Psychiatric Association

Assessment Depression often overlooked in CVD pts Recommend screening all CHD and CHF pts PHQ 2 screen PHQ 9 for any positive screen Referral to mental health specialist for all patients with complex depressive disorders 5Copyright © World Psychiatric Association

Depressive Disorders and Heart Surgery 20% of CABG pts experience major depression within 1 month Depression predicts poor outcome at 1 yr after CABG Heart transplantation regimens require effective treatment of depression to maintain the regimen 6Copyright © World Psychiatric Association

Treatment Options What’s good for the heart is good for the brain –Exercise, fish oil, relaxation training, stress management Citalopram Sertraline Beta blockers do not, in general, cause depression Avoid tricyclic antidepressants in pts with CAD –Risk for arrhythmia following acute coronary syndrome 7Copyright © World Psychiatric Association